Kintor Pharmaceutical Limited
KNTPF News Today: Stay Updated with the Latest Kintor Pharmaceutical Limited News in Real Time
Find KNTPF news now at Meyka AI. Stay informed with the latest Kintor Pharmaceutical Limited stocks updates, including price news, market analysis, and expert insights.
Datalex plc (DLE.IR) Holds Steady at €0.30 Amid Airline Software Demand
DLE.IR trades at €0.30 on EURONEXT. Datalex plc provides airline software with €56.4M market cap amid industry headwinds.
Ypsomed Holding AG Surges 11.8% on Strong Earnings Beat
YPSN.SW stock jumps 11.8% to CHF332.8 after earnings announcement. Medical device maker beats expectations with strong revenue growth.
Ukraine Glide Bomb May 21: Homemade Weapon Targets Russia
Ukraine develops homemade glide bomb with 250kg warhead in 17 months, ready for imminent combat deployment against Russian targets.
Atomos Limited (AMS.AX) Tumbles 20% as Video Tech Firm Battles Profitability Crisis
Atomos Limited (AMS.AX) stock declines on weak fundamentals, negative earnings, and cash burn concerns in consumer electronics.
Walgreens Boots Alliance Stock Edges Up 0.5% on Retail Resilience
WBA stock rises 0.5% to $11.98 amid pharmacy retail strength. Market cap $10.4B, trading above 200-day average.
Hindalco Industries Surges 3.1% Ahead of Earnings Announcement
HINDALCO.NS stock jumps 3.1% to ₹1,085.50 ahead of May 22 earnings. Aluminum producer trades above key moving averages with strong technical momentum.
Choice NV (MLTV.BR) Tumbles 10% as Belgian TV Guide Struggles
MLTV.BR stock drops 10% to €0.18. Choice NV faces steep decline amid weak technical signals and sector headwinds on EURONEXT.
Sapporo Clinical Laboratory Inc. (9776.T) Slips 0.4% in Pre-Market Trade
9776.T stock falls 0.4% to ¥1,952 in pre-market trading on JPX. Healthcare diagnostics firm shows mixed technical signals.
XtalPi Holdings Ltd Slips 3.3% as AI Drug Discovery Faces Valuation Pressure
2228.HK stock drops 3.3% to HK$7.9 amid sector headwinds. XtalPi Holdings faces valuation challenges despite AI-driven drug discovery focus.